Nemolizumab is a first-in-class monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31. 2 IL-31 is a neuroimmune cytokine that drives itch and is ...

In the phase 3 trial, nemolizumab monotherapy showed rapid and sustained improvements in key signs (skin lesions) and ...

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 results published in JAMA Dermatology. The 24-week OLYMPIA 1 trial evaluated the ...

Sorry, your browser doesn't support embedded videos. “These results, alongside the OLYMPIA 2 trial data, formed the basis of nemolizumab’s recent U.S. Food and ...

Global Primary Magnesium Market was valued at US$ 4,792.3 million in 2023 and is projected to surpass the market valuation of US$ 8,028.0 million by 2032 at a CAGR of 5.9% during the forecast period ...

Methods: In this multi-center retrospective study, we collected peripheral blood specimens from a total of 698 patients. A total of 466 patients with ground-glass nodular lung adenocarcinoma no more ...

Medically reviewed by Susan Bard, MD There are a few reasons why it may take time to heal a big pimple. It's normal for some ...